晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02228 晶泰控股

休市中 09-11 16:08:55

6.930

-0.275

-3.82%

最高7.165	最低6.750	成交量5,647万
今开7.155	昨收7.205	日振幅5.76%
总市值298.20亿	流通市值298.20亿	总股本43.03亿
成交额3.89亿	换手率1.31%	流通股本43.03亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":6.93,"timestamp":1789114135003,"preClose":7.205,"halted":0,"volume":56474619,"delay":0,"changeRate":-0.03816793893129776,"floatShares":4303000000,"shares":4303000000,"eps":0.03,"marketStatus":"休市中","change":-0.275,"latestTime":"09-11 16:08:55","open":7.155,"high":7.165,"low":6.75,"amount":388813515,"amplitude":0.057599,"askPrice":6.93,"askSize":262000,"bidPrice":6.92,"bidSize":86000,"shortable":3,"etf":0,"ttmEps":-0.056,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":7,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":7.205,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":1.3791777621567152,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"TPX.HK","impliedVol":0.5548,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/02228","defaultTab":"news","newsList":[{"id":"1167976192","title":"晶泰控股9月11日回购981,000股股份，耗资约675.74万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167976192","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167976192?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:32","pubTimestamp":1789129965,"startTime":"0","endTime":"0","summary":"2026年9月11日，晶泰控股有限公司公告称，公司于当日在香港联交所场内回购普通股981,000股，约占其已发行股本的0.0228%。每股回购价格介乎每股6.88港元至6.90港元，累计支付总金额约675.74万港元。此次回购股份计划作注销处理，截至本次公告日尚未进行注销。公告显示，公司于2026年9月7日至9月11日的已发行股本为4,302,716,179股，另有299,000股为库藏股，合计4,303,015,179股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"晶泰控股9月11日回购981,000股股份，耗资约675.74万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666524111","title":"晶泰控股(02228)9月11日斥资675.74万港元回购98.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666524111","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666524111?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:26","pubTimestamp":1789129577,"startTime":"0","endTime":"0","summary":"晶泰控股(02228)发布公告，于2026年9月11日斥资675.74万港元回购98.1万股。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg40.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg40.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1141","BK1617","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161149702","title":"异动解读｜晶泰控股盘中下跌5.14%，中期业绩由盈转亏持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1161149702","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161149702?lang=zh_cn&edition=full","pubTime":"2026-09-11 10:15","pubTimestamp":1789092942,"startTime":"0","endTime":"0","summary":"9月11日，晶泰控股盘中下跌5.14%，报6.835港元，成交额1.47亿港元。消息面上，公司于9月9日发布中期报告，上半年实现营收3.94亿元人民币，同比下降23.9%；录得净亏损2.25亿元，去年同期为净利润7560万元，业绩由盈转亏。收入下滑主要因去年同期确认一笔5100万美元管线授权首付款形成高基数，药物发现解决方案收入同比骤降54%。经调整净亏损为1.06亿元。同行业个股中，英矽智能同日跌5.75%，板块整体承压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"晶泰控股盘中下跌，中期业绩由盈转亏","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185326117","title":"晶泰控股2026年中期营收3.94亿元，经调整净利润-1.06亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185326117","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185326117?lang=zh_cn&edition=full","pubTime":"2026-09-09 21:33","pubTimestamp":1788960803,"startTime":"0","endTime":"0","summary":"根据公司发布的2026年中期报告显示，晶泰控股在报告期内实现营收3.94亿元，较去年同期的5.17亿元同比下降23.9%。该变化主要由于2025年同期曾确认一笔规模较大的管线授权收入，导致基数较高。经营活动所用净现金流约为3.99亿元，较去年同期的2.38亿元净流出进一步扩大。药物发现解决方案部分实现收入约2.00亿元，较上年同期的4.35亿元下降54.0%，主要原因是对上一报告期内一次性项目收入的高基数影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"晶泰控股2026年中期营收3.94亿元，经调整净利润-1.06亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666536640","title":"晶泰控股：上半财年净亏损2.25亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536640","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666536640?lang=zh_cn&edition=full","pubTime":"2026-09-09 21:31","pubTimestamp":1788960660,"startTime":"0","endTime":"0","summary":"南财智讯9月9日电，晶泰控股（02228.HK）公告，截至2026年6月30日止六个月，集团净亏损人民币224.9百万元，即2.25亿元；去年同期净利润人民币75.6百万元。营业收入为人民币393.6百万元，即3.94亿元，去年同期为人民币517.1百万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609093869565891.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609093869565891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148739690","title":"港股AI医疗概念股表现活跃，剂泰科技-P涨超9%，英矽智能涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148739690","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148739690?lang=zh_cn&edition=full","pubTime":"2026-09-08 10:17","pubTimestamp":1788833835,"startTime":"0","endTime":"0","summary":"9月8日，港股AI医疗概念股表现活跃，$剂泰科技-P(07666)$涨超9%，$英矽智能(03696)$涨超7%，$金斯瑞生物科技(01548)$涨超6%，$云知声(09678)$涨超4%，$医渡科技(02158)$、$晶泰控股(02228)$涨超2%。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","02158","BK4588","QTOC","BK4585","01548","03696","HK0000320264.USD","BK1161","5RE.SI","HK0000320223.HKD","BK1109","BK1141","BK1518","VTHR","BK1583","ARTY","02228","09678","BK1576","VXUS","HK0000306685.HKD","BK1617","07666","KCAI","AIPO","CHAT","HK0000306701.USD","159891","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163854114","title":"晶泰控股9月7日回购29.90万股并注销45.45万股，总耗资约213.94万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163854114","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163854114?lang=zh_cn&edition=full","pubTime":"2026-09-07 21:06","pubTimestamp":1788786388,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司于2026年9月7日公布翌日披露报表，显示公司在当日于香港联交所场内回购29.90万股股份，约占此前已发行股份总数的0.0069%，每股回购价介乎港币7.145元至7.165元，总耗资约213.94万港元。同期，公司另注销45.45万股普通股股份，约占已发行股份总数的0.0106%，注销部分无需支付对价。公告同时提及，公司已严格遵守香港联交所相关上市规则及法律法规，并获得公司董事会正式授权批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"晶泰控股9月7日回购29.90万股并注销45.45万股，总耗资约213.94万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665141003","title":"晶泰控股(02228)9月7日斥资213.94万港元回购29.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665141003","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665141003?lang=zh_cn&edition=full","pubTime":"2026-09-07 21:04","pubTimestamp":1788786282,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股(02228)发布公告，于2026年9月7日斥资213.94万港元回购29.9万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493043.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398249","title":"【券商聚焦】中信建投：上半年收入与利润双增，医药行业步入新发展周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398249","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665398249?lang=zh_cn&edition=full","pubTime":"2026-09-07 09:04","pubTimestamp":1788743053,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，2026年上半年医药行业整体收入与扣非净利润实现双增长，创新药、CXO、制药装备及科学试剂等板块积极复苏，行业步入新发展周期。创新药收入+58.68%，扭亏为盈，出海总金额超900亿美元，全年有望超越2025年水平，国际化持续兑现；CXO收入+25.2%，扣非净利润+66.5%，订单旺盛，上行周期确立。随着集采出清、创新放量、出海落地及上游国产化提升，行业有望开启高质量发展周期，龙头将持续受益。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990791","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","LU0417516902.SGD","LU2778985437.USD","LU2328871848.SGD","KURE","01099","LU2399975544.HKD","LU1720050803.USD","BK1207","IE00B3M56506.USD","02268","LU1115378108.SGD","LU0588546209.SGD","09688","01789","BK1588","06821","LU0348827113.USD","LU0348825331.USD","BK1593","IE00BPRC5H50.USD","LU1969619763.USD","BK1585","01530","BK1515","09926","KCE","02228","LU0228659784.USD","LU0828237510.HKD","SG9999004311.SGD","LU2476274308.USD","BK1583","02367","IE00B5MMRT66.SGD","BK1191","03933","BK1574","601066","BK1197","LU2476274720.SGD","06160","02196","HK0000165453.HKD","LU0640798160.USD","BK1141","LU1770034418.SGD","BK1100","BK1161","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178941301","title":"晶泰控股8月无新增发行，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1178941301","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178941301?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:53","pubTimestamp":1788511999,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司于2026年9月4日发布了截至2026年8月31日的证券变动月报表。公告显示，公司本月股本结构保持稳定，无新增发行或回购注销动作，已发行股份及库存股份数均未发生变化。公司发行在外普通股数量为4,303,469,679股，库存股数量为0股，月内均未发生调整。在股权激励方面，公告显示，首次公开发售前员工持股计划下的股份期权在8月期间累计行使204,000股。公司表示，其公众持股量符合香港联交所的上市规则规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238182","title":"提振信心！晶泰控股两日耗资超1100万港元回购154万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238182","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664238182?lang=zh_cn&edition=full","pubTime":"2026-09-04 13:59","pubTimestamp":1788501554,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1617","02228","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104265519","title":"晶泰控股9月3日回购16.5万股，耗资约118.53万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104265519","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104265519?lang=zh_cn&edition=full","pubTime":"2026-09-03 21:27","pubTimestamp":1788442046,"startTime":"0","endTime":"0","summary":"9月3日，晶泰控股有限公司发布公告，披露公司在9月2日至9月3日期间进行了股份购回。其中，9月2日回购1,375,000股，占购回授权通过当日已发行股本约0.03195%，每股购回均价为港币7.1789元；9月3日回购165,000股，占上述发行股本约0.00383%，每股购回价介乎港币7.18元至7.195元，总金额约港币118.53万元。公告显示，上述回购股份将作注销处理，截至9月3日，公司已发行股本维持在4,303,469,679股，库藏股数量为0。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"晶泰控股9月3日回购16.5万股，耗资约118.53万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100824625","title":"晶泰控股9月2日回购137.5万股股份，涉资约987.10万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100824625","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100824625?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:21","pubTimestamp":1788358917,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司（股票代码：02228）于2026年9月2日发布翌日报表，公告当日公司通过香港联交所场内回购普通股合计1,375,000股，约占公司已发行股本的0.03195%。本次回购的每股价格介乎7.14港元至7.2港元之间，涉资总额约987.10万港元。\n公告显示，公司回购后其已发行股本维持在4,303,469,679股，库藏股数量为0股。晶泰控股指出，此次股份回购已依据2026年5月20日通过的购回授权进行，剩余额度为可回购不超过430,337,176股股份。公司同时确认，本次交易已遵守《香港联合交易所有限公司证券上市规则》等相关法例及监管要求。公告由公司董事温书豪博士签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"晶泰控股9月2日回购137.5万股股份，涉资约987.10万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664134817","title":"晶泰控股(02228.HK)9月2日斥资987.1万港元回购137.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664134817","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664134817?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:20","pubTimestamp":1788358858,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1617","BK1141","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136952563","title":"异动解读｜晶泰控股盘中下跌5.07%，报7.215港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136952563","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136952563?lang=zh_cn&edition=full","pubTime":"2026-08-31 13:03","pubTimestamp":1788152592,"startTime":"0","endTime":"0","summary":"8月31日，晶泰控股盘中下跌5.07%，报7.215港元/股，成交额2.18亿港元。晶泰控股所在的生命科学工具和服务行业整体承压，个股中，药明生物跌5.07%，金斯瑞生物科技跌5.54%，药明康德跌3.96%，药明合联跌4.16%，英矽智能跌6.70%。晶泰控股是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司，主要经营药物发现解决方案及智能自动化解决方案两大业务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"晶泰控股盘中走低，创新药板块集体承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134683447","title":"异动解读｜晶泰控股盘中下跌5.59%，中期由盈转亏叠加前日板块大涨后获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1134683447","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134683447?lang=zh_cn&edition=full","pubTime":"2026-08-21 09:43","pubTimestamp":1787276602,"startTime":"0","endTime":"0","summary":"8月21日，晶泰控股盘中下跌5.59%，报7.595港元，成交额9982.35万港元。研发开支3.68亿元，同比增长66%，主因加大自主实验室及在研管线投入。此外，公司股价前一交易日受mRNA突破消息带动板块联动大涨11.27%，短期获利盘集中回吐形成抛压。晶泰控股是一家AI驱动的药物及材料科学研发平台公司，主要从事药物发现解决方案及智能自动化解决方案业务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"晶泰控股由盈转亏，股价承压回落","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661309236","title":"直击业绩会丨晶泰控股上半年由盈转亏：加码自研管线投入，AI制药“卖水人”要亲自下场“淘金”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2661309236","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661309236?lang=zh_cn&edition=full","pubTime":"2026-08-21 00:13","pubTimestamp":1787242410,"startTime":"0","endTime":"0","summary":"8月19日晚间，港股AI制药龙头晶泰控股（02228.HK）交出了2026年中期“成绩单”。报告期内，公司实现营业收入3.94亿元，同比下降约23.9%；期内净亏损为2.25亿元，而去年同期净利润为7560.9万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608213848232569.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608213848232569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01477","BK1191","QTOC","AIPO","BK1574","CHAT","BK1141","VTHR","ARTY","AGIX","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660340615","title":"晶泰科技(02228)2026中期业绩解码：AI4S商业化高速突破，多模态管线加速兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2660340615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660340615?lang=zh_cn&edition=full","pubTime":"2026-08-20 14:19","pubTimestamp":1787206774,"startTime":"0","endTime":"0","summary":"8月19日，晶泰科技发布2026年中期业绩公告。这是晶泰科技从“AI制药服务商”升级为“贯通数字研发与物理实验的AI4S平台”的第一份中报。截至2026年6月30日，公司现金余额合计86.71亿元，充沛的资金储备为持续研发投入提供保障，巩固公司在AI4S领域领先地位。公司搭建行业领先的全流程AI自主决策实验合成能力，相关业务实现高速增长。相较之下，晶泰科技同时拥有真实落地业务场景、确认收入以及高速迭代的管线储备。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482495.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1617","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660477197","title":"mRNA领域重大突破！创新药概念股飙升，云顶新耀飙升55%，晶泰控股、金斯瑞大涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660477197","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660477197?lang=zh_cn&edition=full","pubTime":"2026-08-20 10:17","pubTimestamp":1787192273,"startTime":"0","endTime":"0","summary":"消息面上，美国制药企业默沙东和莫德纳周三宣布，其实验性信使核糖核酸皮肤癌疫苗在最后阶段临床试验中取得积极结果。专家认为，这是治疗此类癌症的一项“重大突破”。这款名为“intismeran autogene”的新疗法采用mRNA技术。该技术此前已被用于研制新冠疫苗。研究人员多年来一直尝试开发基于mRNA技术的癌症疗法，此次三期临床试验取得积极结果尚属首次。","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2026/08/cms_20260820101753777.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/08/cms_20260820101753777.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/08/20101758183255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","01952","BK1161","IBBQ","MEDX","BK1574","LNGR","02228","06978","BK1617","BK1583","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162366260","title":"港股创新药概念股集体走强，中国生物制药涨超20%，石药集团涨超16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162366260","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162366260?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:59","pubTimestamp":1787191169,"startTime":"0","endTime":"0","summary":"8月20日，港股创新药概念股集体走强，$中国生物制药(01177)$涨超20%，$石药集团(01093)$涨超16%，$晶泰控股(02228)$、$金斯瑞生物科技(01548)$涨超12%，$乐普生物(02157)$、$康方生物(09926)$涨超11%，$荣昌生物(09995)$、$复星医药(02196)$涨超7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","BK1574","LU2476274308.USD","LU2039709279.SGD","LU0348827113.USD","BK1589","BK4588","BK1583","LU0540923850.HKD","LU0348735423.USD","01548","02196","LU1993786604.SGD","BK1593","LU1152091168.USD","SG9999004220.SGD","LU1960683339.HKD","LU0072913022.USD","01177","HK0000320264.USD","LU0348766576.USD","LU1226287529.USD","LU0326950275.SGD","HK0000320223.HKD","BK1161","LU1961090484.USD","02157","LU0634319403.HKD","LU1226287792.SGD","BK1141","HK0000165453.HKD","LU1226288253.USD","LU1720050803.USD","LU2476274720.SGD","HK0000306701.USD","BK1191","LU0501845795.SGD","LU1813983027.USD","LU1794554557.SGD","LU1152091754.HKD","LU0417516738.SGD","BK1515","LU0348825331.USD","159992","06978","BK1521","LU0067412154.USD","IE00B5MMRT66.SGD","LU0348767384.USD","LU0561508036.HKD","BK1617","LU0417516902.SGD","LU1226288170.HKD","LU0880133367.SGD","KCAI","LU2488822045.USD","VXUS","09926","IBBQ","MEDX","09995","IE00BPRC5H50.USD","KURE","IE0008368742.USD","LU1807302812.USD","LU2328871848.SGD","IE00BZ08YS42.EUR","02228","LU1226287875.USD","IE00B031HY20.USD","01093","LU0417516571.SGD","BK1576","IE00B543WZ88.USD","LU0140636845.USD","LU2778985437.USD","IE00BZ08YT58.USD","LNGR","LU2399975544.HKD","BK4585","HK0000306685.HKD","LU0348784397.USD","LU0348783233.USD","IE00BZ08YR35.GBP","LU1328277881.USD","LU1951186391.HKD","LU0314109678.HKD","LU1969619763.USD","LU0315179316.USD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":-0.0546},{"period":"1month","weight":-0.1559},{"period":"3month","weight":-0.0156},{"period":"6month","weight":-0.2705},{"period":"1year","weight":-0.3219},{"period":"ytd","weight":-0.2674}],"compareEarnings":[{"period":"1week","weight":-0.033},{"period":"1month","weight":-0.0249},{"period":"3month","weight":0.0035},{"period":"6month","weight":-0.0259},{"period":"1year","weight":-0.0491},{"period":"ytd","weight":-0.0322}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}